Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy. Ann Surg Oncol. 2016 06; 23(6):1956-62.
View in:
PubMed
subject areas
Adenocarcinoma
Aged
Antineoplastic Combined Chemotherapy Protocols
Chemoradiotherapy, Adjuvant
Combined Modality Therapy
Female
Follow-Up Studies
Gastrectomy
Humans
Lymph Node Excision
Lymph Nodes
Male
Middle Aged
Neoadjuvant Therapy
Prognosis
Retrospective Studies
Stomach Neoplasms
Survival Rate
authors with profiles
Mitchell C. Posner
Mark Talamonti